Hanny K Berger

Title: Hanny K Berger: Innovator in Pharmaceutical Chemistry

Introduction

Hanny K Berger is a notable inventor based in Aesch, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of intermediates for antibacterial agents. Her work exemplifies the intersection of innovation and practical application in medicine.

Latest Patents

Hanny K Berger holds a patent for a process involving methyl-4-(dimethylamino)-3,5-dimethoxybenzoate. This compound serves as an intermediate in the preparation of the antibacterially active aditoprim. The process entails the transformation of 4-amino-3,5-dibromobenzoic acid by replacing the bromine atoms with methoxy groups, followed by a methylation step. This innovative approach highlights her expertise in synthetic organic chemistry.

Career Highlights

Hanny K Berger is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. Her role involves research and development, where she applies her knowledge to create effective pharmaceutical solutions. With her dedication and expertise, she has become a valuable asset to her team and the broader scientific community.

Collaborations

Hanny collaborates with esteemed colleagues such as Alfredo Guerrato and Martin Karpf. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Hanny K Berger's contributions to pharmaceutical chemistry and her innovative patent demonstrate her commitment to advancing medical science. Her work continues to impact the field positively, showcasing the importance of innovation in healthcare.